GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Q2 FY27 Financial Results: PAT ₹25,333 Cr & Revenue ₹92,442 Cr
| Metric | Value |
|---|---|
| Revenue | ₹92,442 Cr |
| Net Profit (PAT) | ₹25,333 Cr |
GlaxoSmithKline Pharmaceuticals announced management changes effective 3rd August 2026, with Ms. Karine J F Natland appointed as Non-Executive Director and Mr. Bhushan Akshikar reappointed as Managing Director for two years starting 1st December 2026. The company also released unaudited standalone and consolidated financial results for Q1 FY2026, showing revenue of ₹98,605 lakhs and ₹98,220 lakhs respectively, with profit after tax of ₹25,333 lakhs (standalone) and ₹23,718 lakhs (consolidated).
About GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when GLAXO files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLAXO — Free💡 Ask AI about this filing
📊 More GLAXO filings
- 🔴 Financial Results — 19 August 2026 GlaxoSmithKline Pharmaceuticals disclosed a tax refund of **₹4.99 crores** received on 18 August 202...
- 🟡 Voting Results — 13 August 2026 GlaxoSmithKline Pharmaceuticals Limited announced a postal ballot for shareholders to vote on two ke...
- Announcement — 21 July 2026 GlaxoSmithKline Pharmaceuticals announced an analyst and institutional investor meeting scheduled fo...
- share transfer — 8 July 2026 GlaxoSmithKline Pharmaceuticals Limited received a SEBI-mandated share transfer agent certificate fo...
- 🟡 concall transcript — 30 June 2026 GlaxoSmithKline Pharmaceuticals reported 15% YoY sales growth to **[amount context mismatch] crores*...
🔥 Also filed on 3 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GLAXO files new disclosures
Track GLAXO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLAXO — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd